Nvidia introduced Cosmos 3 Edge, an edge-optimized world model for robotics and vision AI agents, during CEO Jensen Huang's July 2026 visit to Japan, where the company formalized a physical AI coalition with major Japanese industrial firms including Fujitsu, Hitachi and Kawasaki Heavy Industries. The launch follows the broader Cosmos 3 release in May 2026 and extends Nvidia's platform reach into Japanese healthcare and biotech via agentic AI drug discovery partnerships with Astellas, Daiichi Sankyo and Ono Pharmaceutical. Structurally, this deepens Nvidia's position as the platform layer for physical AI deployment in a market projected to reach $27.9 billion by 2029, reinforcing its role as both hardware supplier and software ecosystem anchor. For financial institutions, the coalition model signals that Nvidia is building enterprise-level switching costs in industrial and life-sciences verticals beyond its core data-center GPU business.
439 other tracked developments touching the same claims.